Maureen Clancy

FAQ About Maureen Clancy

• What is Maureen Clancy's address?

  Maureen Clancy is located at
  Greater Philadelphia, Greater Philadelphia, United States

• What is Maureen Clancy's job title?

  Maureen Clancy is a
  Global Drug Development Program Leader in the biotechnology and pharmaceutical industry accountable for R&D, CMC and Commercial  Champions enterprise data driven drug strategy and execution by collaborating with partners for Fortune 500 (AstraZeneca, Merck, GSK, Novartis, Bristol Myers Squibb) and other pharma and biotech companies.  Open-minded and decisive global program leader prioritizing patient needs, advancing drug indications, and compiling comprehensive evidence packages.  Successfully builds focused high-performing teams and departments that achieve excellence and maximize impact. Specializing in integrating R&D, Commercial and CMC to drive value in oncology, cardiovascular, dermatology, immunology, infection, men’s health, metabolism, neuroscience, orthopedics, rare disease, and urology. Areas of Excellence: Drug Development & Commercialization Strategy and Execution ● Influencing ● Relationship Building ● Asset, Product & Program Leadership ● Talent Management ● Board & C-Level Stakeholder Engagement Strategic Accomplishments: • Led New Drug Application and Biologics License Application submissions, NDA and BLA planning, or launches in oncology, rare disease, dermatology, immunology, metabolism, cardiovascular and infection. • Optimized drug development and commercialization by instituting and streamlining a Global Product Team (GPT) operating model for improved communication, decision-making, and performance, Led GPTs from phase 1 clinical studies to commercial launch planning and life cycle management. • Ensured on-time divestiture of marketed oncology portfolio and late phase assets from GSK to Novartis to balance across pharma, consumer, and vaccines and realize 1.5 billion in annual synergies. Biotech Pharmaceutical Industry Asset, Program and Product Leadership Alliance Management Biomarkers Business Development Chemist Clinical Development Clinical Operations CMC Commercial Companion Diagnostics Culture Data Driven DE&I Executive Stakeholder Management Financial Management Governance Integrated Development Plan M&A, Co-development, Divestiture and In-Licensing Mentor Orphan Drug Precision Medicine Prioritization Program Management R&D Target Product Profile Vision Women Leaders I help organizations by leading drug development, launching products, building teams and capabilities, expanding globally, deploying resources, and strengthening culture. Always open to conversation [email protected] Kura Oncology

• What industry does Maureen Clancy currently work in?

  Maureen Clancy currently works in the
  Kura Oncology

• What is Maureen Clancy's area of expertise?

  Maureen Clancy specializes in
  Global Drug Development Program Leader in the biotechnology and pharmaceutical industry accountable for R&D, CMC and Commercial  Champions enterprise data driven drug strategy and execution by collaborating with partners for Fortune 500 (AstraZeneca, Merck, GSK, Novartis, Bristol Myers Squibb) and other pharma and biotech companies.  Open-minded and decisive global program leader prioritizing patient needs, advancing drug indications, and compiling comprehensive evidence packages.  Successfully builds focused high-performing teams and departments that achieve excellence and maximize impact. Specializing in integrating R&D, Commercial and CMC to drive value in oncology, cardiovascular, dermatology, immunology, infection, men’s health, metabolism, neuroscience, orthopedics, rare disease, and urology. Areas of Excellence: Drug Development & Commercialization Strategy and Execution ● Influencing ● Relationship Building ● Asset, Product & Program Leadership ● Talent Management ● Board & C-Level Stakeholder Engagement Strategic Accomplishments: • Led New Drug Application and Biologics License Application submissions, NDA and BLA planning, or launches in oncology, rare disease, dermatology, immunology, metabolism, cardiovascular and infection. • Optimized drug development and commercialization by instituting and streamlining a Global Product Team (GPT) operating model for improved communication, decision-making, and performance, Led GPTs from phase 1 clinical studies to commercial launch planning and life cycle management. • Ensured on-time divestiture of marketed oncology portfolio and late phase assets from GSK to Novartis to balance across pharma, consumer, and vaccines and realize 1.5 billion in annual synergies. Biotech Pharmaceutical Industry Asset, Program and Product Leadership Alliance Management Biomarkers Business Development Chemist Clinical Development Clinical Operations CMC Commercial Companion Diagnostics Culture Data Driven DE&I Executive Stakeholder Management Financial Management Governance Integrated Development Plan M&A, Co-development, Divestiture and In-Licensing Mentor Orphan Drug Precision Medicine Prioritization Program Management R&D Target Product Profile Vision Women Leaders I help organizations by leading drug development, launching products, building teams and capabilities, expanding globally, deploying resources, and strengthening culture. Always open to conversation [email protected]

• Which languages does Maureen Clancy speak? 

  Maureen Clancy speaks the following languages:
  No languages available.

• Which industries has Maureen Clancy previously worked in?   

  Maureen Clancy has prior experience in the following industries:
  Endo Pharmaceuticals , Gsk , Astrazeneca , Merck

• What is Maureen Clancy’s work experience?  

  Maureen Clancy has the following professional experience:
  Kura Oncology , Endo Pharmaceuticals , Gsk , Astrazeneca , Merck .

• How can I find Maureen Clancy on LinkedIn?  

  You can view Maureen Clancy’s
  LinkedIn profile at LinkedIn URL.

• What are Maureen Clancy’s work email addresses?  

  Maureen Clancy’s work email addresses are
  [email protected] .

• What company does Maureen Clancy work for?  

  Maureen Clancy works at
  Kura Oncology